The frequency and clinical aspects of Barrett’s esophagus in elderly patients
DOI: https://doi.org/10.29296/25877305-2019-06-08
Issue:
6
Year:
2019
Barrett’s esophagus (BE) in elderly patients is a serious clinical problem. Attentive, qualified diagnosis, treatment, and prevention are required in BE. The frequency and clinical aspects of BE have been studied in elderly patients.
Keywords:
gastroenterology
gastroesophageal reflux disease
Barrett’s esophagus
elderly patients
frequency
References:
- Achem S., DeVault K. Gastroesophageal reflux disease and the elderly // Gastroenterol. Clin. North Am. – 2014; 43 (1): 147–60. DOI: 10.1016/j.gtc.2013.11.004.
- Johnson D., Fennerty M. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease // Gastroenterology. – 2004; 126 (3): 660–4. DOI: 10.1053/j.gastro.2003.12.001.
- Okimoto E., Ishimura N., Morito Y. et al. Prevalence of gastroesophageal reflux disease in children, adults, and elderly in the same community // J. Gastroenterol. Hepatol. – 2015; 30 (7): 1140–6. DOI: 10.1111/jgh.12899.
- Coleman H., Xie S., Lagergren J. The Epidemiology of Esophageal Adenocarcinoma // Gastroenterology. – 2018; 154 (2): 390–405. DOI: 10.1053/j.gastro.2017.07.046.
- Bashashati M., Sarosiek I., McCallum R. Epidemiology and mechanisms of gastroesophageal reflux disease in the elderly: a perspective // Ann. N. Y. Acad. Sci. –2016; 1380 (1): 230–4. DOI: 10.1111/nyas.13196.
- Vakil N., van Zanten S., Kahrilas P. et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus // Am. J. Gastroenterol. – 2006; 101 (8): 1900–20. DOI: 10.1111/j.1572-0241.2006.00630.x.
- Lundell L., Dent J., Bennet J. et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification // Gut. – 1999; 45 (2): 172–80. DOI: 10.1136/gut.45.2.172.
- Modlin I., Hunt R., Malfertheiner P. et al. Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group // Digestion. – 2009; 80 (2): 74–88. DOI: 10.1159/000219365.
- Fitzgerald R., di Pietro M., Ragunath K. et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus // Gut. – 2014; 63 (1): 7–42. DOI: 10.1136/gutjnl-2013-305372.
- Tsukanov V.V., Onuchina E.V., Vasjutin A.V. i dr. Taktika vedenija bol'nyh gastroezofageal'noj refljuksnoj bolezn'ju s vnepischevodnymi sindromami // Farmateka. – 2015; 6: 11–4 [Tsukanov V.V., Onuchina E.V., Vasyutin A.V. et al. Management of GERD patients with extraesophageal syndromes // Farmateka. – 2015; 6: 11–4 (in Russ.)].
- Weusten B., Bisschops R., Coron E. et al. Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement // Endoscopy. – 2017; 49 (2): 191–8. DOI: 10.1055/s-0042-122140.
- Shaheen N., Falk G., Iyer P. et al. ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus // Am. J. Gastroenterol. – 2016; 111 (1): 30–50. DOI: 10.1038/ajg.2015.322.
- Fock K., Talley N., Goh K. et al. Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett’s oesophagus // Gut. – 2016; 65 (9): 1402–15. DOI: 10.1136/gutjnl-2016-311715.
- Clermont M., Falk G. Clinical Guidelines Update on the Diagnosis and Management of Barrett’s Esophagus // Dig. Dis. Sci. – 2018; 63 (8): 2122–8. DOI: 10.1007/s10620-018-5070-z.
- Pohl H., Pech O., Arash H. et al. Length of Barrett’s oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma // Gut. – 2016; 65 (2): 196–201. DOI: 10.1136/gutjnl-2015-309220.
- Whiteman D., Appleyard M., Bahin F. et al. Australian clinical practice guidelines for the diagnosis and management of Barrett’s esophagus and early esophageal adenocarcinoma // J. Gastroenterol. Hepatol. – 2015; 30 (5): 804–20. DOI: 10.1111/jgh.12913.
- Rajendra S., Sharma P. Barrett’s Esophagus // Curr. Treat. Options Gastroenterol. – 2014; 12 (2): 169–82. DOI: 10.1007/s11938-014-0012-0.
- Pandey G., Mulla M., Lewis W. et al. Systematic review and meta-analysis of the effectiveness of radiofrequency ablation in low grade dysplastic Barrett’s esophagus // Endoscopy. – 2018; 50 (10): 953–60. DOI: 10.1055/a-0588-5151.
- Singh S., Garg S., Singh P. et al. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett’s oesophagus: a systematic review and meta-analysis // Gut. – 2014; 63 (8): 1229–37. DOI: 10.1136/gutjnl-2013-305997.
- Freedberg D., Kim L., Yang Y. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association // Gastroenterology. – 2017; 152 (4): 706–15. DOI: 10.1053/j.gastro.2017.01.031.
- Wassenaar E., Oelschlager B. Effect of medical and surgical treatment of Barrett’s metaplasia // World J. Gastroenterol. – 2010; 16 (30): 3773–9. DOI: 10.3748/wjg.v16.i30.3773.
- Rayner C., Gatenby P. Effect of antireflux surgery for Barrett’s esophagus: long-term results // Minerva Chir. – 2016; 71 (3): 180–91.
- Rugge M., Genta R., Graham D. et al. Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment // Gut. – 2016; 65 (5): 721–5. DOI: 10.1136/gutjnl-2015-310846.
- Tsukanov V.V., Amel'chugova O.S., Kasparov E.V. i dr. Rol' eradikatsii Helicobacter pylori v profilaktike raka zheludka // Ter. arh. – 2014; 86 (8): 124–7 [Tsukanov V.V., Amel’chugova O.S., Kasparov E.V. et al. Role of Helicobacter pylori eradication in the prevention of gastric cancer // Ter. Arkh. – 2014; 86 (8): 124–7 (in Russ.)].